EVI is a non-profit Product Development Partnership supporting the development of vaccines for diseases of poverty by bridging conceptual and operational gaps in translational research. EVI supports strengthening of the vaccine R&D infrastructure in Europe, harmonisation, knowledge sharing, and aligning of major vaccine R&D stakeholders. EVI has extensive experience of almost 20 years in coordinating and participating in large scale infrastructure and collaborative research projects funded by the EC and other funders. EVI’s mission is to lead European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision is a world free of the intolerable burden of diseases of poverty within the coming decades'.
Role in the TRANSVAC project
EVI’s main role in TRANSVAC is to handle the daily Coordination and Management of the project. This includes: Coordination of project activities Ensuring adherence to technical, financial, legal and contractual guidelines; Reporting project progress to the EC Ensuring good communication within the project and with external stakeholders; Dissemination of the projects achievements; Managing the project’s Calls for Users; Managing the project’s external advisory committees, i.e. SEAC, USP and BoS.
Main staff involved in TRANSVAC
Dr. Hilde Depraetere, Project Leader; Dr. Monika Ślęzak, Project Manager; Dr. Catarina Luís, Project and Communication Manager; Dr. Nicola Viebig, Project Manager Stakeholders; Sten Larsen, Finance Director
EVI provides a fully equipped Project Management Office with its headquarters in Heidelberg, Germany.